Skip to content

Trial for the Treatment of Acute Asthma in Wheezy Pre-school Aged Children

A Double Blind Randomized Control Trail of Azithromycin for the Acute Management of Wheezy Pre-school Children

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01008761
Enrollment
440
Registered
2009-11-06
Start date
2010-01-31
Completion date
2013-12-31
Last updated
2012-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Pre-school child, Wheezy episode

Brief summary

To determine if treatment of pre-school children with a history of wheeze who present to an Emergency Department with an acute wheezing episode with azithromycin for 5 days will resolve their symptoms more quickly, will require less short acting beta agonist (SABA), and allow these children to remain symptom free for a longer period of time.

Interventions

DRUGAzithromycin

Azithromycin given at 10 mg/kg/day for day 1, then 5 mg/kg for 4 days Each syringe will contain 12.5 mls (250 mgs) sufficient drug to adequately dose children who with up to 25 kgs (95%tile for weight for 60 month old child)

DRUGSuspension Placebo

Placebo suspension will be administered on day 1 at 10mg/kg and then for the next 4 days at 5 mg/kg

Sponsors

University of Alberta
CollaboratorOTHER
Janielee Williamson
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Months to 60 Months
Healthy volunteers
No

Inclusion criteria

* 12-60 months * wheeze on auscultation

Exclusion criteria

* antibiotic use in the past 30 days * macrolide allergy * underlying medical condition * significant co-morbidities * current enrollment * language barrier or no access to phone for follow up

Design outcomes

Primary

MeasureTime frame
To determine if treatment of pre-school children with a history of wheeze who present to an Emergency department (ED) with an acute wheezing episode with Azithromycin for 5 days will resolve their symptoms more quicklyPatient is followed by phone day 1,3,5,7,14, with an in person return visit on day 21 and then by phone again every 2 weeks for 6 months

Secondary

MeasureTime frame
Treatment of pre-school children with acute wheezing symptoms with 5 days of azithromycin will cause these children to use less rescue beta2 agonists than those treated with placeboPatient is followed by phone day 1,3,5,7,14, with an in person return visit on day 21 and then by phone again every 2 weeks for 6 months
Treatment of pre-school children with acute wheezing symptoms with 5 days of azithromycin will allow these children to remain free of subsequent wheezy episodes longer than those treated with placebo.Patient is followed by phone day 1,3,5,7,14, with an in person return visit on day 21 and then by phone again every 2 weeks for 6 months

Countries

Canada

Contacts

Primary ContactJanielee Williamson, RN
janie.williamson@albertahealthservices.ca403-955-3186
Backup ContactDavid W. Johnson, MD
david.johnson@alberthealthservices.ca403-955-7507

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026